Skip to main navigation Skip to search Skip to main content

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

  • Johann de Bono
  • , Chia Chi Lin
  • , Li Tzong Chen
  • , Jesus Corral
  • , Vasiliki Michalarea
  • , Karim Rihawi
  • , Michael Ong
  • , Jih Hsiang Lee
  • , Chih Hung Hsu
  • , James Chih Hsin Yang
  • , Her Shyong Shiah
  • , Chia Jui Yen
  • , Alan Anthoney
  • , Maria Jove
  • , Susanne Buschke
  • , René Fuertig
  • , Ulrike Schmid
  • , Rainer Georg Goeldner
  • , Natalja Strelkowa
  • , Dennis Chin Lun Huang
    • Thomas Bogenrieder, Chris Twelves, Ann Lii Cheng

Research output: Contribution to journal › Article › peer-review

36   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology